Alibaba
BABA
Meta Platforms
META
Taiwan Semiconductor
TSM
4
Oracle
ORCL
5
ASML Holding
ASML
US Stock MarketDetailed Quotes
KALV KalVista Pharmaceuticals
- 13.550
- -0.050-0.37%
Close May 2 16:00 ET
- 14.811
- +1.261+9.30%
Post 20:01 ET
673.65MMarket Cap-3.59P/E (TTM)
13.910High13.445Low520.72KVolume13.660Open13.600Pre Close7.12MTurnover1.79%Turnover RatioLossP/E (Static)49.72MShares15.50052wk High4.64P/B393.93MFloat Cap7.30052wk Low--Dividend TTM29.07MShs Float129.108Historical High--Div YieldTTM3.42%Amplitude4.120Historical Low13.677Avg Price1Lot Size
About KalVista Pharmaceuticals Company
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Cambridge, MA.
Company Profile
SymbolKALV
Company NameKalVista Pharmaceuticals
Listing DateApr 9, 2015
Issue Price9.51
Founded2004
CEOMr. Benjamin L. Palleiko
MarketNASDAQ
Employees150
Fiscal Year Ends04-30
Address55 Cambridge Parkway,Suite 901 East
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-857-999-0075
Websitehttp://www.kalvista.com
Company Executives
- Name
- Position
- Salary
- Benjamin L. Palleiko
- Chief Executive Officer and Director
- 6.77M
- Christopher M. Yea, PhD
- Chief Development Officer
- 1.37M
- Dr. Paul K. Audhya, M.B.A.,M.D.
- Chief Medical Officer
- 1.83M
- Brian Piekos
- Chief Financial Officer and Principal Accounting Officer
- --
- Jebediah T. Ledell
- Chief Operating Officer
- --
- Dr. Brian J.G. Pereira,M.D.
- Chairman of the Board
- 161.60K
- Nancy Stuart
- Independent Director
- 136.60K
- William Carl Fairey
- Independent Director
- 143.78K
- Patrick Treanor, M.B.A.
- Independent Director
- 124.10K
- Edward W. Unkart
- Independent Director
- 136.60K
- Dr. Laurence E. Reid, PhD
- Independent Director
- --
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025